DSIP 5mg
Delta Sleep-Inducing Peptide — synthetic nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) Originally isolated from rabbit brain tissue (1977) — studied in neuroendocrine research CAS 62568-57-4 For in vitro neuroendocrine research only
For laboratory research use only. Not for human or veterinary consumption. SKU DS5.
Product details.
Specifications
| Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu |
| Amino Acids | 9 |
| Molecular Formula | C₃₅H₄₈N₁₀O₁₅ |
| Molecular Weight | 848.81 g/mol |
| CAS Number | 62568-57-4 |
| Form | Lyophilized powder |
| Quantity | 5mg per vial |
Research landscape
Preclinical studies have examined DSIP in EEG delta-wave sleep architecture, circadian rhythm gene expression, and hypothalamic neuropeptide signaling. Additional research has investigated interactions with the hormonal axis — ACTH and cortisol secretion patterns, LH release kinetics, and somatostatin pathway crosstalk. The nonapeptide has been characterized for its ability to cross experimental blood-brain barrier models, and a separate line of investigation examines its modulation of CRF (corticotropin-releasing factor) pathways and adrenal axis regulation in stress response models.
Frequently paired with
- Selank 5mg — Neuroendocrine and stress pathway research.
Quality and testing
Every Heritage Labs compound is manufactured to research-grade standards and shipped in protective packaging.
Storage
- Lyophilized: -20°C
- Reconstituted: 2-8°C, use within 30 days
For laboratory research use only. Not for human or veterinary use.
FDA Disclaimer. All products are for research use only (RUO) as defined by the FDA — not for diagnostic, human, or veterinary use. These products have not been evaluated and have not been approved by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
Heritage Labs is a chemical supplier providing products strictly for laboratory research, analytical, and in-vitro purposes; it is not a compounding pharmacy or compounding facility under Section 503A, nor an outsourcing facility under Section 503B, of the Federal Food, Drug, and Cosmetic Act.




